UPADACITINIB vs USTEKINUMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
UPADACITINIB vs USTEKINUMAB: Safety Overview
| Metric | UPADACITINIB | USTEKINUMAB |
|---|---|---|
| Total FAERS Reports | 65,656 | 85,332 |
| Deaths Reported | 2,406 | 4,519 |
| Death Rate | 3.7% | 5.3% |
| Hospitalizations | 15,931 | 17,127 |
| Average Patient Age | 57.4 yrs | 48.1 yrs |
| % Female Patients | 71.2% | 60.3% |
| FDA Approval Date | Apr 26, 2024 | N/A |
| Manufacturer | AbbVie Inc. | SANDOZ INC |
| Route | ORAL | SUBCUTANEOUS |
| Marketing Status | Prescription | Prescription |